Filana Therapeutics, Inc. Earnings Per Share (Basic)
Filana Therapeutics, Inc. (FLNA) reported Earnings Per Share (Basic) of -$0.21 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-05-07
- Filana Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.21.
- Filana Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.26.
- Filana Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.22.
- Filana Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.92, a 807.69% decline year-over-year.
- Filana Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$1.88.
- Filana Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$0.53.
- Filana Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$2.32.
- Filana Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$1.90.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$0.21 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.48 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.40 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.88 10-K · filed 2026-03-12 |
| 2025-09-30 | -$0.22 10-Q · filed 2025-11-12 | -$1.14 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$1.62 10-Q · filed 2025-11-12 | -$2.20 derived: net income ÷ weighted average shares · filed 2026-05-07 |
| 2025-06-30 | -$0.92 10-Q · filed 2025-08-14 | -$1.40 10-Q · filed 2025-08-14 | -$1.97 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$2.56 derived: net income ÷ weighted average shares · filed 2026-05-07 |
| 2025-03-31 | -$0.48 10-Q · filed 2026-05-07 | -$1.06 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$1.64 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$1.53 derived: net income ÷ weighted average shares · filed 2026-05-07 |
| 2024-12-31 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.16 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.04 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.53 10-K · filed 2026-03-12 |
| 2024-09-30 | -$0.58 10-Q · filed 2025-11-12 | -$0.46 derived: net income ÷ weighted average shares · filed 2025-11-12 | $0.07 10-Q · filed 2025-11-12 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2024-06-30 | $0.13 10-Q · filed 2025-08-14 | $0.70 10-Q · filed 2025-08-14 | $0.23 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2024-03-31 | $0.58 10-Q · filed 2025-05-08 | $0.10 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$0.51 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.13 derived: net income ÷ weighted average shares · filed 2026-04-28 |
| 2023-12-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.11 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$1.74 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$2.32 10-K · filed 2026-03-12 |
| 2023-09-30 | -$0.61 10-Q · filed 2024-11-07 | -$1.24 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.82 10-Q · filed 2024-11-07 | -$2.30 derived: net income ÷ weighted average shares · filed 2025-03-03 |
| 2023-06-30 | -$0.63 10-Q · filed 2024-08-08 | -$1.21 10-Q · filed 2024-08-08 | -$1.68 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$2.19 derived: net income ÷ weighted average shares · filed 2025-03-03 |
| 2023-03-31 | -$0.58 10-Q · filed 2024-05-10 | -$1.05 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$1.56 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$2.04 derived: net income ÷ weighted average shares · filed 2025-03-03 |
| 2022-12-31 | -$0.47 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$0.97 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$1.46 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$1.90 10-K · filed 2025-03-03 |
| 2022-09-30 | -$0.51 10-Q · filed 2023-11-07 | -$0.99 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.43 10-Q · filed 2023-11-07 | |
| 2022-06-30 | -$0.48 10-Q · filed 2023-08-03 | -$0.92 10-Q · filed 2023-08-03 | ||
| 2021-12-31 | -$0.82 10-K · filed 2024-02-28 | |||
| 2015-12-31 | -$0.31 10-K · filed 2016-03-03 | |||
| 2014-12-31 | -$0.27 10-K · filed 2016-03-03 | |||
| 2013-12-31 | $0.73 10-K · filed 2016-03-03 | $0.70 10-K · filed 2016-03-03 | ||
| 2013-09-30 | -$0.02 10-K · filed 2016-03-03 | |||
| 2013-06-30 | -$0.01 10-K · filed 2016-03-03 | |||
| 2013-03-31 | -$0.01 10-K · filed 2016-03-03 | |||
| 2012-12-31 | -$0.08 10-K · filed 2015-02-18 | |||
| 2012-03-31 | $0.00 derived: net income ÷ weighted average shares · filed 2013-04-24 | |||
| 2011-12-31 | -$0.06 10-K · filed 2014-02-05 | |||
| 2011-03-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |